141 related articles for article (PubMed ID: 1610354)
1. Effects of endogenous soluble beta-galactoside binding lectins and protein inhibitor of fucosyltransferase on the enzymes involved in the intestinal fucosylation process.
Ruggiero-Lopez D; Louisot P; Martin A
Biochem Biophys Res Commun; 1992 Jun; 185(2):617-23. PubMed ID: 1610354
[TBL] [Abstract][Full Text] [Related]
2. Participation of an endogenous inhibitor of fucosyltransferase activities in the developmental regulation of intestinal fucosylation processes.
Ruggiero-Lopez D; Biol MC; Louisot P; Martin A
Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):801-6. PubMed ID: 1953674
[TBL] [Abstract][Full Text] [Related]
3. [Characterization and postnatal evolution of an endogenous protein inhibitor of intestinal fucosyltransferase activities].
Ruggiero-Lopez D; Martin A; Louisot P
Gastroenterol Clin Biol; 1991; 15(12):939-44. PubMed ID: 1664396
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of secretory-type GDP-L-fucose: beta-D-galactoside 2-alpha-L-fucosyltransferase from human gastric mucosa.
Masutani H; Kimura H
J Biochem; 1995 Sep; 118(3):541-5. PubMed ID: 8690714
[TBL] [Abstract][Full Text] [Related]
5. Glycosyltransferases of the human cervical epithelium. I. Characterization of a beta-galactoside alpha-2-L-fucosyltransferase and the identification of a beta-N-acetylglucosaminide alpha-3-L-fucosyltransferase.
Scudder PR; Chantler EN
Biochim Biophys Acta; 1981 Jul; 660(1):128-35. PubMed ID: 6168291
[TBL] [Abstract][Full Text] [Related]
6. A bisubstrate analog inhibitor for alpha(1----2)-fucosyltransferase.
Palcic MM; Heerze LD; Srivastava OP; Hindsgaul O
J Biol Chem; 1989 Oct; 264(29):17174-81. PubMed ID: 2551897
[TBL] [Abstract][Full Text] [Related]
7. Purification and separation of two soluble fucosyltransferase activities of small intestinal mucosa.
Martin A; Biol MC; Richard M; Louisot P
Comp Biochem Physiol B; 1987; 87(4):725-31. PubMed ID: 3665424
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and analysis of potential α1,3-fucosyltransferase inhibitors.
Seelhorst K; Piernitzki T; Lunau N; Meier C; Hahn U
Bioorg Med Chem; 2014 Nov; 22(22):6430-7. PubMed ID: 25438767
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the presence of an endogenous cytosolic protein inhibitor of intestinal fucosyltransferase activities.
Martin A; Ruggiero-Lopez D; Biol MC; Louisot P
Biochem Biophys Res Commun; 1990 Jan; 166(2):1024-31. PubMed ID: 2302220
[TBL] [Abstract][Full Text] [Related]
10. Role of insulin and nutritional factors in intestinal glycoprotein fucosylation during postnatal development.
Biol MC; Lenoir D; Greco S; Galvain D; Hugueny I; Louisot P
Am J Physiol; 1998 Nov; 275(5):G936-42. PubMed ID: 9815021
[TBL] [Abstract][Full Text] [Related]
11. Developmental changes in intestinal glycosylation: nutrition-dependent multi-factor regulation of the fucosylation pathway at weaning time.
Lenoir D; Ruggiero-Lopez D; Louisot P; Biol MC
Biochim Biophys Acta; 1995 Mar; 1234(1):29-36. PubMed ID: 7533541
[TBL] [Abstract][Full Text] [Related]
12. Acceptor specificity of different length constructs of human recombinant alpha 1,3/4-fucosyltransferases. Replacement of the stem region and the transmembrane domain of fucosyltransferase V by protein A results in an enzyme with GDP-fucose hydrolyzing activity.
de Vries T; Srnka CA; Palcic MM; Swiedler SJ; van den Eijnden DH; Macher BA
J Biol Chem; 1995 Apr; 270(15):8712-22. PubMed ID: 7721776
[TBL] [Abstract][Full Text] [Related]
13. Increased alpha3-fucosylation of alpha(1)-acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG-Ia).
Van Dijk W; Koeleman C; Van het Hof B; Poland D; Jakobs C; Jaeken J
FEBS Lett; 2001 Apr; 494(3):232-5. PubMed ID: 11311246
[TBL] [Abstract][Full Text] [Related]
14. A sequence motif involved in the donor substrate binding by alpha1,6-fucosyltransferase: the role of the conserved arginine residues.
Takahashi T; Ikeda Y; Tateishi A; Yamaguchi Y; Ishikawa M; Taniguchi N
Glycobiology; 2000 May; 10(5):503-10. PubMed ID: 10764839
[TBL] [Abstract][Full Text] [Related]
15. Inhibition kinetics of carba- and C-fucosyl analogues of GDP-fucose against fucosyltransferase V: implication for the reaction mechanism.
Norris AJ; Whitelegge JP; Strouse MJ; Faull KF; Toyokuni T
Bioorg Med Chem Lett; 2004 Feb; 14(3):571-3. PubMed ID: 14741245
[TBL] [Abstract][Full Text] [Related]
16. Mouse lymphoma cell lines resistant to pea lectin are defective in fucose metabolism.
Reitman ML; Trowbridge IS; Kornfeld S
J Biol Chem; 1980 Oct; 255(20):9900-6. PubMed ID: 6159350
[TBL] [Abstract][Full Text] [Related]
17. Differential gene expression of GDP-L-fucose-synthesizing enzymes, GDP-fucose transporter and fucosyltransferase VII.
Niittymäki J; Mattila P; Renkonen R
APMIS; 2006; 114(7-8):539-48. PubMed ID: 16907860
[TBL] [Abstract][Full Text] [Related]
18. Photoaffinity labeling of GDP-fucose:nLcOse4Cer alpha 1----3-fucosyltransferase from human small cell lung carcinoma NCI-H69 cells with the GDP-fucose analog GDP-hexanolaminyl-4-azidosalicylic acid.
Holmes EH
J Biol Chem; 1990 Aug; 265(22):13150-6. PubMed ID: 2165495
[TBL] [Abstract][Full Text] [Related]
19. Presence of an essential lysine residue in a GDP-fucose protected site of the alpha 1----3fucosyltransferase from human small cell lung carcinoma NCl-H69 cells.
Holmes EH
Arch Biochem Biophys; 1992 Aug; 296(2):562-8. PubMed ID: 1321590
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of human alpha-1,3-fucosyltransferase V: glycosidic cleavage occurs prior to nucleophilic attack.
Murray BW; Wittmann V; Burkart MD; Hung SC; Wong CH
Biochemistry; 1997 Jan; 36(4):823-31. PubMed ID: 9020780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
